Trial Profile
Effects of teneligliptin on serum lipid profile and insulin resistance in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 29 Aug 2014 New trial record